Viewing Study NCT00055432


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2025-12-25 @ 7:38 PM
Study NCT ID: NCT00055432
Status: TERMINATED
Last Update Posted: 2006-09-15
First Post: 2003-03-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module